137 related articles for article (PubMed ID: 12128170)
1. Effects of 12 Ca2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression.
Takara K; Sakaeda T; Tanigawara Y; Nishiguchi K; Ohmoto N; Horinouchi M; Komada F; Ohnishi N; Yokoyama T; Okumura K
Eur J Pharm Sci; 2002 Aug; 16(3):159-65. PubMed ID: 12128170
[TBL] [Abstract][Full Text] [Related]
2. Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil.
Kakumoto M; Sakaeda T; Takara K; Nakamura T; Kita T; Yagami T; Kobayashi H; Okamura N; Okumura K
Cancer Sci; 2003 Jan; 94(1):81-6. PubMed ID: 12708479
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4.
Katoh M; Nakajima M; Yamazaki H; Yokoi T
Pharm Res; 2000 Oct; 17(10):1189-97. PubMed ID: 11145223
[TBL] [Abstract][Full Text] [Related]
4. Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport.
Takara K; Sakaeda T; Kakumoto M; Tanigawara Y; Kobayashi H; Okumura K; Ohnishi N; Yokoyama T
Oncol Res; 2009; 17(11-12):527-33. PubMed ID: 19806783
[TBL] [Abstract][Full Text] [Related]
5. Interaction of digoxin with antihypertensive drugs via MDR1.
Takara K; Kakumoto M; Tanigawara Y; Funakoshi J; Sakaeda T; Okumura K
Life Sci; 2002 Feb; 70(13):1491-500. PubMed ID: 11895100
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C
J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606
[TBL] [Abstract][Full Text] [Related]
7. Digoxin up-regulates MDR1 in human colon carcinoma Caco-2 cells.
Takara K; Tsujimoto M; Ohnishi N; Yokoyama T
Biochem Biophys Res Commun; 2002 Mar; 292(1):190-4. PubMed ID: 11890691
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.
Pauli-Magnus C; von Richter O; Burk O; Ziegler A; Mettang T; Eichelbaum M; Fromm MF
J Pharmacol Exp Ther; 2000 May; 293(2):376-82. PubMed ID: 10773005
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures.
Hirsch-Ernst KI; Ziemann C; Rustenbeck I; Kahl GF
Toxicology; 2001 Oct; 167(1):47-57. PubMed ID: 11557129
[TBL] [Abstract][Full Text] [Related]
10. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
[TBL] [Abstract][Full Text] [Related]
11. Reversal effects of antifungal drugs on multidrug resistance in MDR1-overexpressing HeLa cells.
Iida N; Takara K; Ohmoto N; Nakamura T; Kimura T; Wada A; Hirai M; Sakaeda T; Okumura K
Biol Pharm Bull; 2001 Sep; 24(9):1032-6. PubMed ID: 11558564
[TBL] [Abstract][Full Text] [Related]
12. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
Shirakawa K; Takara K; Tanigawara Y; Aoyama N; Kasuga M; Komada F; Sakaeda T; Okumura K
Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657
[TBL] [Abstract][Full Text] [Related]
13. MDR1-mediated interaction of digoxin with antiarrhythmic or antianginal drugs.
Kakumoto M; Takara K; Sakaeda T; Tanigawara Y; Kita T; Okumura K
Biol Pharm Bull; 2002 Dec; 25(12):1604-7. PubMed ID: 12499648
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects of 27 anticancer drugs in HeLa and MDR1-overexpressing derivative cell lines.
Takara K; Sakaeda T; Yagami T; Kobayashi H; Ohmoto N; Horinouchi M; Nishiguchi K; Okumura K
Biol Pharm Bull; 2002 Jun; 25(6):771-8. PubMed ID: 12081145
[TBL] [Abstract][Full Text] [Related]
15. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin and lovastatin, but not pravastatin, interact with MDR1.
Sakaeda T; Takara K; Kakumoto M; Ohmoto N; Nakamura T; Iwaki K; Tanigawara Y; Okumura K
J Pharm Pharmacol; 2002 Mar; 54(3):419-23. PubMed ID: 11902809
[TBL] [Abstract][Full Text] [Related]
17. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
18. Haloperidol is an inhibitor but not substrate for MDR1/P-glycoprotein.
Iwaki K; Sakaeda T; Kakumoto M; Nakamura T; Komoto C; Okamura N; Nishiguchi K; Shiraki T; Horinouchi M; Okumura K
J Pharm Pharmacol; 2006 Dec; 58(12):1617-22. PubMed ID: 17331325
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line.
Massart C; Gibassier J; Raoul M; Pourquier P; Leclech G; Robert J; Lucas C
Anticancer Drugs; 1995 Feb; 6(1):135-46. PubMed ID: 7756676
[TBL] [Abstract][Full Text] [Related]
20. Effect of rabeprazole on MDR1-mediated transport of Rhodamine 123 in Caco-2 and Hvr100-6 cells.
Itagaki F; Homma M; Takara K; Ohnishi N; Yokoyama T; Sakaeda T; Yagami T; Kobayashi H; Okamura N; Kohda Y
Biol Pharm Bull; 2004 Oct; 27(10):1694-6. PubMed ID: 15467223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
